1,428
Views
0
CrossRef citations to date
0
Altmetric
Article

Patients’ willingness to accept adverse event and cost tradeoffs from oral nicotinamide for reduced risk of non-melanoma skin cancer

ORCID Icon, , , , &
Article: 2247105 | Received 11 Jul 2023, Accepted 07 Aug 2023, Published online: 17 Aug 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.